img

Global Insulin Glargine and Lispro Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Insulin Glargine and Lispro Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Lantus (insulin glargine) is an effective, long-acting insulin that provides all-day blood sugar control, but it can cause low blood sugar levels, so be sure to have a source of sugar nearby. Lowers blood sugar. Humalog (insulin lispro) is a fast-acting insulin that controls blood sugar around meal times.
Insulin Glargine and Lispro report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Insulin Glargine and Lispro market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Type I Dibetes and Type II Dibetes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Insulin Glargine and Lispro industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Insulin Glargine and Lispro key manufacturers include Sanofi S.A, Eli Lilly and Company, Biocon Limited, Cipla Limited, Gan & Lee Pharmaceutical Ltd., Julphar Diabetes LLC, Merck & Co., Novo Nordisk A/S and SAJA Pharmaceuticals, etc. Sanofi S.A, Eli Lilly and Company, Biocon Limited are top 3 players and held % sales share in total in 2022.
Insulin Glargine and Lispro can be divided into Branded Drug and Biosimilar Drug, etc. Branded Drug is the mainstream product in the market, accounting for % sales share globally in 2022.
Insulin Glargine and Lispro is widely used in various fields, such as Type I Dibetes and Type II Dibetes, etc. Type I Dibetes provides greatest supports to the Insulin Glargine and Lispro industry development. In 2022, global % sales of Insulin Glargine and Lispro went into Type I Dibetes filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insulin Glargine and Lispro market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi S.A
Eli Lilly and Company
Biocon Limited
Cipla Limited
Gan & Lee Pharmaceutical Ltd.
Julphar Diabetes LLC
Merck & Co.
Novo Nordisk A/S
SAJA Pharmaceuticals
Wockhardt Ltd.
Segment by Type
Branded Drug
Biosimilar Drug

Segment by Application


Type I Dibetes
Type II Dibetes

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insulin Glargine and Lispro market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Insulin Glargine and Lispro, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Insulin Glargine and Lispro industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Insulin Glargine and Lispro in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Insulin Glargine and Lispro introduction, etc. Insulin Glargine and Lispro Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Insulin Glargine and Lispro market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Insulin Glargine and Lispro Market Overview
1.1 Insulin Glargine and Lispro Product Overview
1.2 Insulin Glargine and Lispro Market Segment by Type
1.2.1 Branded Drug
1.2.2 Biosimilar Drug
1.3 Global Insulin Glargine and Lispro Market Size by Type
1.3.1 Global Insulin Glargine and Lispro Market Size Overview by Type (2018-2034)
1.3.2 Global Insulin Glargine and Lispro Historic Market Size Review by Type (2018-2024)
1.3.3 Global Insulin Glargine and Lispro Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Glargine and Lispro Sales Breakdown by Type (2018-2024)
1.4.2 Europe Insulin Glargine and Lispro Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Insulin Glargine and Lispro Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Insulin Glargine and Lispro Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Insulin Glargine and Lispro Sales Breakdown by Type (2018-2024)
2 Global Insulin Glargine and Lispro Market Competition by Company
2.1 Global Top Players by Insulin Glargine and Lispro Sales (2018-2024)
2.2 Global Top Players by Insulin Glargine and Lispro Revenue (2018-2024)
2.3 Global Top Players by Insulin Glargine and Lispro Price (2018-2024)
2.4 Global Top Manufacturers Insulin Glargine and Lispro Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Glargine and Lispro Market Competitive Situation and Trends
2.5.1 Insulin Glargine and Lispro Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Glargine and Lispro Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Glargine and Lispro as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Glargine and Lispro Market
2.8 Key Manufacturers Insulin Glargine and Lispro Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Glargine and Lispro Status and Outlook by Region
3.1 Global Insulin Glargine and Lispro Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Insulin Glargine and Lispro Historic Market Size by Region
3.2.1 Global Insulin Glargine and Lispro Sales in Volume by Region (2018-2024)
3.2.2 Global Insulin Glargine and Lispro Sales in Value by Region (2018-2024)
3.2.3 Global Insulin Glargine and Lispro Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Insulin Glargine and Lispro Forecasted Market Size by Region
3.3.1 Global Insulin Glargine and Lispro Sales in Volume by Region (2024-2034)
3.3.2 Global Insulin Glargine and Lispro Sales in Value by Region (2024-2034)
3.3.3 Global Insulin Glargine and Lispro Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Insulin Glargine and Lispro by Application
4.1 Insulin Glargine and Lispro Market Segment by Application
4.1.1 Type I Dibetes
4.1.2 Type II Dibetes
4.2 Global Insulin Glargine and Lispro Market Size by Application
4.2.1 Global Insulin Glargine and Lispro Market Size Overview by Application (2018-2034)
4.2.2 Global Insulin Glargine and Lispro Historic Market Size Review by Application (2018-2024)
4.2.3 Global Insulin Glargine and Lispro Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Glargine and Lispro Sales Breakdown by Application (2018-2024)
4.3.2 Europe Insulin Glargine and Lispro Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Insulin Glargine and Lispro Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Insulin Glargine and Lispro Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Insulin Glargine and Lispro Sales Breakdown by Application (2018-2024)
5 North America Insulin Glargine and Lispro by Country
5.1 North America Insulin Glargine and Lispro Historic Market Size by Country
5.1.1 North America Insulin Glargine and Lispro Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Insulin Glargine and Lispro Sales in Volume by Country (2018-2024)
5.1.3 North America Insulin Glargine and Lispro Sales in Value by Country (2018-2024)
5.2 North America Insulin Glargine and Lispro Forecasted Market Size by Country
5.2.1 North America Insulin Glargine and Lispro Sales in Volume by Country (2024-2034)
5.2.2 North America Insulin Glargine and Lispro Sales in Value by Country (2024-2034)
6 Europe Insulin Glargine and Lispro by Country
6.1 Europe Insulin Glargine and Lispro Historic Market Size by Country
6.1.1 Europe Insulin Glargine and Lispro Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Insulin Glargine and Lispro Sales in Volume by Country (2018-2024)
6.1.3 Europe Insulin Glargine and Lispro Sales in Value by Country (2018-2024)
6.2 Europe Insulin Glargine and Lispro Forecasted Market Size by Country
6.2.1 Europe Insulin Glargine and Lispro Sales in Volume by Country (2024-2034)
6.2.2 Europe Insulin Glargine and Lispro Sales in Value by Country (2024-2034)
7 Asia-Pacific Insulin Glargine and Lispro by Region
7.1 Asia-Pacific Insulin Glargine and Lispro Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Glargine and Lispro Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Insulin Glargine and Lispro Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Insulin Glargine and Lispro Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Insulin Glargine and Lispro Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Glargine and Lispro Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Insulin Glargine and Lispro Sales in Value by Region (2024-2034)
8 Latin America Insulin Glargine and Lispro by Country
8.1 Latin America Insulin Glargine and Lispro Historic Market Size by Country
8.1.1 Latin America Insulin Glargine and Lispro Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Insulin Glargine and Lispro Sales in Volume by Country (2018-2024)
8.1.3 Latin America Insulin Glargine and Lispro Sales in Value by Country (2018-2024)
8.2 Latin America Insulin Glargine and Lispro Forecasted Market Size by Country
8.2.1 Latin America Insulin Glargine and Lispro Sales in Volume by Country (2024-2034)
8.2.2 Latin America Insulin Glargine and Lispro Sales in Value by Country (2024-2034)
9 Middle East and Africa Insulin Glargine and Lispro by Country
9.1 Middle East and Africa Insulin Glargine and Lispro Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Glargine and Lispro Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Insulin Glargine and Lispro Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Insulin Glargine and Lispro Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Insulin Glargine and Lispro Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Glargine and Lispro Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Insulin Glargine and Lispro Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi S.A
10.1.1 Sanofi S.A Company Information
10.1.2 Sanofi S.A Introduction and Business Overview
10.1.3 Sanofi S.A Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi S.A Insulin Glargine and Lispro Products Offered
10.1.5 Sanofi S.A Recent Development
10.2 Eli Lilly and Company
10.2.1 Eli Lilly and Company Company Information
10.2.2 Eli Lilly and Company Introduction and Business Overview
10.2.3 Eli Lilly and Company Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Eli Lilly and Company Insulin Glargine and Lispro Products Offered
10.2.5 Eli Lilly and Company Recent Development
10.3 Biocon Limited
10.3.1 Biocon Limited Company Information
10.3.2 Biocon Limited Introduction and Business Overview
10.3.3 Biocon Limited Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biocon Limited Insulin Glargine and Lispro Products Offered
10.3.5 Biocon Limited Recent Development
10.4 Cipla Limited
10.4.1 Cipla Limited Company Information
10.4.2 Cipla Limited Introduction and Business Overview
10.4.3 Cipla Limited Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Cipla Limited Insulin Glargine and Lispro Products Offered
10.4.5 Cipla Limited Recent Development
10.5 Gan & Lee Pharmaceutical Ltd.
10.5.1 Gan & Lee Pharmaceutical Ltd. Company Information
10.5.2 Gan & Lee Pharmaceutical Ltd. Introduction and Business Overview
10.5.3 Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Products Offered
10.5.5 Gan & Lee Pharmaceutical Ltd. Recent Development
10.6 Julphar Diabetes LLC
10.6.1 Julphar Diabetes LLC Company Information
10.6.2 Julphar Diabetes LLC Introduction and Business Overview
10.6.3 Julphar Diabetes LLC Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Julphar Diabetes LLC Insulin Glargine and Lispro Products Offered
10.6.5 Julphar Diabetes LLC Recent Development
10.7 Merck & Co.
10.7.1 Merck & Co. Company Information
10.7.2 Merck & Co. Introduction and Business Overview
10.7.3 Merck & Co. Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck & Co. Insulin Glargine and Lispro Products Offered
10.7.5 Merck & Co. Recent Development
10.8 Novo Nordisk A/S
10.8.1 Novo Nordisk A/S Company Information
10.8.2 Novo Nordisk A/S Introduction and Business Overview
10.8.3 Novo Nordisk A/S Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Novo Nordisk A/S Insulin Glargine and Lispro Products Offered
10.8.5 Novo Nordisk A/S Recent Development
10.9 SAJA Pharmaceuticals
10.9.1 SAJA Pharmaceuticals Company Information
10.9.2 SAJA Pharmaceuticals Introduction and Business Overview
10.9.3 SAJA Pharmaceuticals Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.9.4 SAJA Pharmaceuticals Insulin Glargine and Lispro Products Offered
10.9.5 SAJA Pharmaceuticals Recent Development
10.10 Wockhardt Ltd.
10.10.1 Wockhardt Ltd. Company Information
10.10.2 Wockhardt Ltd. Introduction and Business Overview
10.10.3 Wockhardt Ltd. Insulin Glargine and Lispro Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Wockhardt Ltd. Insulin Glargine and Lispro Products Offered
10.10.5 Wockhardt Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Glargine and Lispro Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Glargine and Lispro Industrial Chain Analysis
11.4 Insulin Glargine and Lispro Market Dynamics
11.4.1 Insulin Glargine and Lispro Industry Trends
11.4.2 Insulin Glargine and Lispro Market Drivers
11.4.3 Insulin Glargine and Lispro Market Challenges
11.4.4 Insulin Glargine and Lispro Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Glargine and Lispro Distributors
12.3 Insulin Glargine and Lispro Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Branded Drug
Table 2. Major Company of Biosimilar Drug
Table 3. Global Insulin Glargine and Lispro Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Insulin Glargine and Lispro Sales by Type (2018-2024) & (Liter)
Table 5. Global Insulin Glargine and Lispro Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Insulin Glargine and Lispro Sales by Type (2018-2024) & (US& Million)
Table 7. Global Insulin Glargine and Lispro Market Share in Value by Type (2018-2024)
Table 8. Global Insulin Glargine and Lispro Price by Type (2018-2024) & (USD/mL)
Table 9. Global Insulin Glargine and Lispro Sales by Type (2024-2034) & (Liter)
Table 10. Global Insulin Glargine and Lispro Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Insulin Glargine and Lispro Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Insulin Glargine and Lispro Sales Market Share in Value by Type (2024-2034)
Table 13. Global Insulin Glargine and Lispro Price by Type (2024-2034) & (USD/mL)
Table 14. North America Insulin Glargine and Lispro Sales by Type (2018-2024) & (Liter)
Table 15. North America Insulin Glargine and Lispro Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Insulin Glargine and Lispro Sales (Liter) by Type (2018-2024)
Table 17. Europe Insulin Glargine and Lispro Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Insulin Glargine and Lispro Sales (Liter) by Type (2018-2024)
Table 19. Asia-Pacific Insulin Glargine and Lispro Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Insulin Glargine and Lispro Sales (Liter) by Type (2018-2024)
Table 21. Latin America Insulin Glargine and Lispro Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Insulin Glargine and Lispro Sales (Liter) by Type (2018-2024)
Table 23. Middle East and Africa Insulin Glargine and Lispro Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Insulin Glargine and Lispro Sales by Company (2018-2024) & (Liter)
Table 25. Global Insulin Glargine and Lispro Sales Share by Company (2018-2024)
Table 26. Global Insulin Glargine and Lispro Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Insulin Glargine and Lispro Revenue Share by Company (2018-2024)
Table 28. Global Market Insulin Glargine and Lispro Price by Company (2018-2024) & (USD/mL)
Table 29. Global Insulin Glargine and Lispro Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Insulin Glargine and Lispro Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Glargine and Lispro as of 2022)
Table 32. Date of Key Manufacturers Enter into Insulin Glargine and Lispro Market
Table 33. Key Manufacturers Insulin Glargine and Lispro Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Insulin Glargine and Lispro Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Insulin Glargine and Lispro Sales by Region (2018-2024) & (Liter)
Table 37. Global Insulin Glargine and Lispro Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Insulin Glargine and Lispro Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Insulin Glargine and Lispro Sales Market Share in Value by Region (2018-2024)
Table 40. Global Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2018-2024)
Table 41. Global Insulin Glargine and Lispro Sales by Region (2024-2034) & (Liter)
Table 42. Global Insulin Glargine and Lispro Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Insulin Glargine and Lispro Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Insulin Glargine and Lispro Sales Market Share in Value by Region (2024-2034)
Table 45. Global Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2024-2034)
Table 46. Global Insulin Glargine and Lispro Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Insulin Glargine and Lispro Sales by Application (2018-2024) & (Liter)
Table 48. Global Insulin Glargine and Lispro Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Insulin Glargine and Lispro Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Insulin Glargine and Lispro Sales Market Share in Value by Application (2018-2024)
Table 51. Global Insulin Glargine and Lispro Price by Application (2018-2024) & (USD/mL)
Table 52. Global Insulin Glargine and Lispro Sales by Application (2024-2034) & (Liter)
Table 53. Global Insulin Glargine and Lispro Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Insulin Glargine and Lispro Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Insulin Glargine and Lispro Sales Market Share in Value by Application (2024-2034)
Table 56. Global Insulin Glargine and Lispro Price by Application (2024-2034) & (USD/mL)
Table 57. North America Insulin Glargine and Lispro Sales by Application (2018-2024) (Liter)
Table 58. North America Insulin Glargine and Lispro Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Insulin Glargine and Lispro Sales by Application (2018-2024) (Liter)
Table 60. Europe Insulin Glargine and Lispro Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Insulin Glargine and Lispro Sales by Application (2018-2024) (Liter)
Table 62. Asia-Pacific Insulin Glargine and Lispro Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Insulin Glargine and Lispro Sales by Application (2018-2024) (Liter)
Table 64. Latin America Insulin Glargine and Lispro Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Insulin Glargine and Lispro Sales by Application (2018-2024) (Liter)
Table 66. Middle East and Africa Insulin Glargine and Lispro Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Insulin Glargine and Lispro Sales by Country (2018-2024) & (Liter)
Table 68. North America Insulin Glargine and Lispro Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Insulin Glargine and Lispro Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Insulin Glargine and Lispro Sales Market Share in Value by Country (2018-2024)
Table 71. North America Insulin Glargine and Lispro Sales by Country (2024-2034) & (Liter)
Table 72. North America Insulin Glargine and Lispro Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Insulin Glargine and Lispro Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Insulin Glargine and Lispro Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Insulin Glargine and Lispro Sales by Country (2018-2024) & (Liter)
Table 76. Europe Insulin Glargine and Lispro Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Insulin Glargine and Lispro Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Insulin Glargine and Lispro Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Insulin Glargine and Lispro Sales by Country (2024-2034) & (Liter)
Table 80. Europe Insulin Glargine and Lispro Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Insulin Glargine and Lispro Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Insulin Glargine and Lispro Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Insulin Glargine and Lispro Sales by Region (2018-2024) & (Liter)
Table 84. Asia-Pacific Insulin Glargine and Lispro Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Insulin Glargine and Lispro Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Insulin Glargine and Lispro Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Insulin Glargine and Lispro Sales by Region (2024-2034) & (Liter)
Table 88. Asia-Pacific Insulin Glargine and Lispro Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Insulin Glargine and Lispro Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Insulin Glargine and Lispro Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Insulin Glargine and Lispro Sales by Country (2018-2024) & (Liter)
Table 92. Latin America Insulin Glargine and Lispro Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Insulin Glargine and Lispro Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Insulin Glargine and Lispro Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Insulin Glargine and Lispro Sales by Country (2024-2034) & (Liter)
Table 96. Latin America Insulin Glargine and Lispro Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Insulin Glargine and Lispro Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Insulin Glargine and Lispro Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Insulin Glargine and Lispro Sales by Country (2018-2024) & (Liter)
Table 100. Middle East and Africa Insulin Glargine and Lispro Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Insulin Glargine and Lispro Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Insulin Glargine and Lispro Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Insulin Glargine and Lispro Sales by Country (2024-2034) & (Liter)
Table 104. Middle East and Africa Insulin Glargine and Lispro Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Insulin Glargine and Lispro Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Insulin Glargine and Lispro Sales Market Share in Value by Country (2024-2034)
Table 107. Sanofi S.A Company Information
Table 108. Sanofi S.A Introduction and Business Overview
Table 109. Sanofi S.A Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 110. Sanofi S.A Insulin Glargine and Lispro Product
Table 111. Sanofi S.A Recent Development
Table 112. Eli Lilly and Company Company Information
Table 113. Eli Lilly and Company Introduction and Business Overview
Table 114. Eli Lilly and Company Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 115. Eli Lilly and Company Insulin Glargine and Lispro Product
Table 116. Eli Lilly and Company Recent Development
Table 117. Biocon Limited Company Information
Table 118. Biocon Limited Introduction and Business Overview
Table 119. Biocon Limited Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 120. Biocon Limited Insulin Glargine and Lispro Product
Table 121. Biocon Limited Recent Development
Table 122. Cipla Limited Company Information
Table 123. Cipla Limited Introduction and Business Overview
Table 124. Cipla Limited Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 125. Cipla Limited Insulin Glargine and Lispro Product
Table 126. Cipla Limited Recent Development
Table 127. Gan & Lee Pharmaceutical Ltd. Company Information
Table 128. Gan & Lee Pharmaceutical Ltd. Introduction and Business Overview
Table 129. Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 130. Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Product
Table 131. Gan & Lee Pharmaceutical Ltd. Recent Development
Table 132. Julphar Diabetes LLC Company Information
Table 133. Julphar Diabetes LLC Introduction and Business Overview
Table 134. Julphar Diabetes LLC Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 135. Julphar Diabetes LLC Insulin Glargine and Lispro Product
Table 136. Julphar Diabetes LLC Recent Development
Table 137. Merck & Co. Company Information
Table 138. Merck & Co. Introduction and Business Overview
Table 139. Merck & Co. Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 140. Merck & Co. Insulin Glargine and Lispro Product
Table 141. Merck & Co. Recent Development
Table 142. Novo Nordisk A/S Company Information
Table 143. Novo Nordisk A/S Introduction and Business Overview
Table 144. Novo Nordisk A/S Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 145. Novo Nordisk A/S Insulin Glargine and Lispro Product
Table 146. Novo Nordisk A/S Recent Development
Table 147. SAJA Pharmaceuticals Company Information
Table 148. SAJA Pharmaceuticals Introduction and Business Overview
Table 149. SAJA Pharmaceuticals Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 150. SAJA Pharmaceuticals Insulin Glargine and Lispro Product
Table 151. SAJA Pharmaceuticals Recent Development
Table 152. Wockhardt Ltd. Company Information
Table 153. Wockhardt Ltd. Introduction and Business Overview
Table 154. Wockhardt Ltd. Insulin Glargine and Lispro Sales (Liter), Revenue (Million USD), Price (USD/mL) and Gross Margin (2018-2024)
Table 155. Wockhardt Ltd. Insulin Glargine and Lispro Product
Table 156. Wockhardt Ltd. Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Insulin Glargine and Lispro Market Trends
Table 160. Insulin Glargine and Lispro Market Drivers
Table 161. Insulin Glargine and Lispro Market Challenges
Table 162. Insulin Glargine and Lispro Market Restraints
Table 163. Insulin Glargine and Lispro Distributors List
Table 164. Insulin Glargine and Lispro Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Glargine and Lispro Product Picture
Figure 2. Global Insulin Glargine and Lispro Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Insulin Glargine and Lispro Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Insulin Glargine and Lispro Sales Status and Outlook (2018-2034) & (Liter)
Figure 5. Product Picture of Branded Drug
Figure 6. Global Branded Drug Sales YoY Growth (2018-2034) & (Liter)
Figure 7. Product Picture of Biosimilar Drug
Figure 8. Global Biosimilar Drug Sales YoY Growth (2018-2034) & (Liter)
Figure 9. Global Insulin Glargine and Lispro Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Insulin Glargine and Lispro Sales Market Share by Type in 2022 & 2034
Figure 11. North America Insulin Glargine and Lispro Sales Market Share in Volume by Type in 2022
Figure 12. North America Insulin Glargine and Lispro Sales Market Share in Value by Type in 2022
Figure 13. Europe Insulin Glargine and Lispro Sales Market Share in Volume by Type in 2022
Figure 14. Europe Insulin Glargine and Lispro Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Insulin Glargine and Lispro Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Insulin Glargine and Lispro Sales Market Share in Value by Type in 2022
Figure 17. Latin America Insulin Glargine and Lispro Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Insulin Glargine and Lispro Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Insulin Glargine and Lispro Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Insulin Glargine and Lispro Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Glargine and Lispro Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Glargine and Lispro Revenue in 2022
Figure 23. Insulin Glargine and Lispro Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Type I Dibetes
Figure 25. Global Type I Dibetes Sales YoY Growth (2018-2034) & (Liter)
Figure 26. Product Picture of Type II Dibetes
Figure 27. Global Type II Dibetes Sales YoY Growth (2018-2034) & (Liter)
Figure 28. Global Insulin Glargine and Lispro Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Insulin Glargine and Lispro Sales Market Share by Application in 2022 & 2034
Figure 30. North America Insulin Glargine and Lispro Sales Market Share in Volume by Application in 2022
Figure 31. North America Insulin Glargine and Lispro Sales Market Share in Value by Application in 2022
Figure 32. Europe Insulin Glargine and Lispro Sales Market Share in Volume by Application in 2022
Figure 33. Europe Insulin Glargine and Lispro Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Insulin Glargine and Lispro Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Insulin Glargine and Lispro Sales Market Share in Value by Application in 2022
Figure 36. Latin America Insulin Glargine and Lispro Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Insulin Glargine and Lispro Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Insulin Glargine and Lispro Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Insulin Glargine and Lispro Manufacturing Cost Structure
Figure 41. Insulin Glargine and Lispro Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries